https://www.selleckchem.com/products/PI-103.html
High-dose intravenous immunoglobulin (IVIg) therapy has pharmacological suppressive actions against phagocytosis, complement system, pathogenic autoantibodies, and inflammatory cytokines, making it an effective treatment for autoimmune diseases. Unfortunately, there is no established evidence of the efficacy of IVIg therapy for autoimmune diseases of the central nervous system. Patients who are resistant to steroids and other immunosuppressive therapies or have complications that preclude the use of strong immunosuppressive therapies are
Like
Comment
Share
